abstract |
The present invention relates to compositions, methods and kits for the treatment of fibrosis. In particular, the compositions, methods and kits are particularly useful, but not exclusively, in the treatment of cardiac fibrosis. The present invention provides a method of treating fibrosis in an individual comprising administering a selective AT2R agonist, thereby treating fibrosis. |